Bionano Genomics, Inc. (BNGO) Net Margin

BNGO (Bionano Genomics) - company brandmark

Bionano Genomics, Inc. (BNGO) is scaling DNA analysis through strategic alliances with laboratories and the implementation of AI. The technological superiority of Saphyr and patent protection create a significant barrier to entry for competitors. Market capitalization is based on the deployment of hardware and software. The net sales yield ratio on the GURU.Markets terminal chart shows that the indicator is at -96.90.

bionanogenomics.com (BNGO) - Company Sales Margin from 07/04/2022 to 11/20/2026

Summary analytical data breakdowns for Bionano Genomics Inc. (BNGO)

- market value and analyst target forecast:
Summary company analytics:Bionano Genomics - BNGO
Manufactured product of Bionano Genomics

Sales margins serve as a key filter during asset stress testing to evaluate actual profitability. This ratio measures the share of net profit in total revenue, demonstrating the ultimate efficiency of cost management. By analyzing net margin dynamics, an investor can see the ability of Bionano Genomics, Inc. (BNGO) to monetize the delivery of equipment and software. An increase in this indicator confirms the optimization of production costs for genome mapping systems, while a decrease signals rising costs in the implementation of high-tech products.

Competitors of Bionano Genomics, Inc. (BNGO)

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|LXEO: Net Sales Margin|Korro Bio Inc. - Net Profit Rate|EDIT (editasmedicine.com) - Net Sales Margin|Net Margin SLN|Net Margin ProQR Therapeutics NV (PRQR)|Codexis - Net Return on Sales|Net Margin Sangamo SGMO|NAUT: Net Return on Sales|MGX: Return on Sales by Net Profit|Net Margin Precision BioSciences|GBIO (generationbio.com) - Return on Sales by Net Profit|Net Margin boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Net Sales Margin|Net Return on Sales IMNN (Imunon, Inc.)|Net Sales Margin PHIO|MBIO - Net Margin|Net Sales Margin RNAZ (TransCode Therapeutics)|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX